P. Michielsen
About
In The Last Decade
P. Michielsen
202 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 128
- Epidemiology 2.1k
- Hepatology 1.5k
- Surgery 662
- Molecular Biology 472
- Endocrinology, Diabetes and Metabolism 392
Countries citing papers authored by P. Michielsen
This map shows the geographic impact of P. Michielsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Michielsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Michielsen more than expected).
Fields of papers citing papers by P. Michielsen
This network shows the impact of papers produced by P. Michielsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Michielsen. The network helps show where P. Michielsen may publish in the future.
Co-authorship network of co-authors of P. Michielsen
This figure shows the co-authorship network connecting the top 25 collaborators of P. Michielsen. A scholar is included among the top collaborators of P. Michielsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Michielsen. P. Michielsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 7 | |
| 3 | Response of Black African patients with hepatitis C virus genotype 4 to treatment with peg-interferon and ribavirin. | 1 |
| 4 | Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C? | 8 |
| 5 | 6 | |
| 6 | 102 | |
| 7 | IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use? | 1 |
| 8 | Treatment of chronic hepatitis C in patients with human immunodeficiency virus (HIV) with weekly peginterferon alpha-2b plus ribavirin: a multi-centred Belgian study. | 1 |
| 9 | Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust study. | 3 |
| 10 | Daily induction combination treatment with alfa2b interferon or standard combination treatment in naive chronic hepatitis C patients. A controlled multicenter randomized trail. | 0 |
| 11 | Prevention of vertical transmission of hepatitis B virus infection. Is there a standard policy in Flanders (Belgium)? | 1 |
| 12 | Hepatitis B in België: epidemiologie en vaccinatiebeleid | 0 |
| 13 | Interleukin-12 induces responses to HBsAg in chronic HBV carriers | 0 |
| 14 | Organ shortage--what to do? | 3 |
| 15 | Altruism, self-determination, and organ procurement efficiency: the European experience. The Leuven Collaborative Group for Transplantation. | 5 |
| 16 | 2 | |
| 17 | 19 | |
| 18 | 11 | |
| 19 | [Colonic complications in kidney transplantation]. | 0 |
| 20 | La conservation du rein: méthodes et évaluation fonctionnelle. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.